CRC
SAGE

Curi RMB Capital’s Sage Therapeutics SAGE Stock Holding History

Curi RMB Capital’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,289
Closed -$882K – 727
2019
Q3 		$882K Hold
6,289
– – 0.02% 403
2019
Q2 		$1.15M Buy
6,289
+6
+0.1% +$1.02K 0.03% 391
2019
Q1 		$999K Sell
6,283
-5,514
-47% -$799K 0.03% 449
2018
Q4 		$1.13M Sell
11,797
-496
-4% -$56.8K 0.03% 476
2018
Q3 		$1.74M Sell
12,293
-1,140
-8% -$176K 0.04% 413
2018
Q2 		$2.1M Sell
13,433
-6,555
-33% -$1.03M 0.05% 369
2018
Q1 		$3.22M Sell
19,988
-6,359
-24% -$1.08M 0.08% 309
2017
Q4 		$4.34M Sell
26,347
-14,903
-36% -$1.44M 0.11% 250
2017
Q3 		$2.57M Hold
41,250
– – 0.07% 336
2017
Q2 		$3.29M Buy
+41,250
New +$2.98M 0.09% 292

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return